CO2 Laser System (MBT- CO2 Laser)
Beijing Mega Beauty Technology Co., Ltd. · Decision date Sep 1, 2026
What did the FDA decide?
FDA recorded a substantial equivalence decision dated September 1, 2026 for the CO2 Laser System (MBT- CO2 Laser), submitted by Beijing Mega Beauty Technology Co., Ltd. under K262269. The product code is GEX and the listed specialty is General, Plastic Surgery. Substantial equivalence means the submission was cleared to market; it is not premarket approval of a new device.
The available record identifies the device as a CO2 laser system and, in the decision letter excerpt, describes use for human tissue vaporization and coagulation in dermatology and plastic surgery and general surgery. The excerpt also lists biological evaluation standards for skin sensitization and related testing. The record does not state a predicate device, the specific component or change reviewed, or the full indications and labeling, so those points remain unknown from this data.
Readers should not infer clinical performance, comparative safety, or current labeling from the clearance alone. The listed specialty and product code are administrative classifications, and the letter excerpt is not a complete statement of cleared indications.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Sep 1, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262269
- Regulatory pathway
- 510(k) premarket notification
- Product code
- GEX
- Decision code
- SESE
- Decision date
- Sep 1, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Powered Laser Surgical Instrument.
- Product code
- GEX
- FDA device class
- 2
FDA decision timeline
K262269 received
Application receipt date recorded by FDA.
K262269 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code GEX
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Single Use Optical FiberK262886 | Quanta System Spa | 510(k) clearance | Nov 5, 2026 | FDA |
| Borze, Inc. | 510(k) clearance | Oct 30, 2026 | FDA | |
| Risu Medical Technology Co., Ltd. | 510(k) clearance | Oct 27, 2026 | FDA | |
| Sanhe PERFECTLASER Technology Co., Ltd. | 510(k) clearance | Oct 26, 2026 | FDA | |
| Beijing Sea Heart International Science and Technologyco.Ltd | 510(k) clearance | Oct 22, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Beijing Mega Beauty Technology Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Beijing
Sources and methodology
- Original FDA record: K262269
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


